Clinical Trials Logo

Cesarean Delivery clinical trials

View clinical trials related to Cesarean Delivery.

Filter by:

NCT ID: NCT04812223 Completed - Cesarean Delivery Clinical Trials

Timing of Umbilical Cord Clamping in Term Cesarean Deliveries

Start date: March 25, 2021
Phase: N/A
Study type: Interventional

The aim of this study is to show that delayed umbilical cord clamping or milking of the umbilical cord in pregnant women undergoing elective cesarean delivery might have better effects than early clamping, on neonatal results without causing maternal hemorrhage or negatively affecting the neonatal outcome , and to compare the superiority of these three methods to each other.

NCT ID: NCT04799587 Completed - Pregnancy Related Clinical Trials

Accupressure of P6 to Reduce Nausea During Cesarean Section

Start date: May 26, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate if the addition of P6 pressure point stimulation as opposed to sham-point stimulation will decrease intraoperative and postoperative nausea and vomiting (IONV and PONV) for patients undergoing non-emergent cesarean delivery. We hypothesize that the addition of stimulation of the P6 pressure point to our institutional current standard of care (phenylephrine infusion, intravenous fluid bolus, and as needed intraoperative ondansetron) will decrease the occurrence of intraoperative emesis.

NCT ID: NCT04601246 Completed - Opioid Use Clinical Trials

Understanding the Postpartum Pain Experience in Women of Minority Race/Ethnicity

Start date: December 1, 2020
Phase:
Study type: Observational

This study will evaluate women's experiences with pain management and perceived attitudes regarding opioid use for postpartum pain management and examine differences by race/ ethnicity. Women will participate in in-depth qualitative interviews regarding their postpartum pain experience after a cesarean delivery. In this cohort, the investigators will evaluate how experiences of postpartum pain management and perceptions of provider attitudes vary across self-identified race/ethnicity. When applicable, mixed methods integration of patient-reported and clinical data from NNM2 will also allow exploration of patient factors contributing to such variation.

NCT ID: NCT04358757 Completed - Cesarean Delivery Clinical Trials

Immune and Physical Recovery Following Cesarean Delivery

Start date: November 22, 2019
Phase:
Study type: Observational

Pregnancy results in an altered immune state compared to the nonpregnant population. A significant proportion of women undergoing cesarean delivery recover poorly. The first step to determining whether this is an immune driven / associated process is to characterise what effects this surgery has on maternal immune function. "Normal" changes will be evaluated in maternal immune function and activity precipitated by surgery and delivery of the neonate. Immune response to surgery will be compared to historical immune data from patients undergoing non-obstetric surgery (orthopaedic patients).

NCT ID: NCT04349215 Completed - Cesarean Delivery Clinical Trials

Validation of the Chinese ObsQoR-11

Start date: March 9, 2020
Phase:
Study type: Observational

Investigation of post-cesarean recovery among Taiwanese pregnant women.

NCT ID: NCT04250233 Completed - Clinical trials for Cesarean Delivery; Neuraxial Opioids

Respiratory Rate After Cesarean Delivery

Start date: August 11, 2021
Phase:
Study type: Observational

The study proposal summarizes aspects related to respiratory rate in women who undergo spinal anesthesia for cesarean delivery who receive or do not receive neuraxial opioids

NCT ID: NCT04199156 Completed - Spinal Anesthesia Clinical Trials

Evaluation of Non-invasive Blood Pressure Measured at the Ankle During Cesarean Delivery Compared to the Arm

Start date: January 1, 2020
Phase:
Study type: Observational

Spinal anesthesia-induced maternal hypotension during cesarean delivery is hazardous to the mother and the fetus. Prevention of the unfavorable outcomes of maternal hypotension includes various fluid and vasopressor protocols, and requires careful, frequent monitoring of blood pressure during the first 30 minutes after spinal block. Many clinicians set the blood pressure measurement intervals at 1- minute or 2-minutes intervals during the early period after spinal block. it had been reported that hypotension of duration less than 2 minutes is not harmful to the neonate; thus, the minimum inter-measurement intervals for blood pressure readings should be 2 minutes. This high frequency of blood pressure measurements commonly leads to patient dis-satisfaction due to pain as well as impairment of the interaction with the fetus after delivery. Moreover, the blood pressure measurement in the upper limbs could be affected by movement and shivering. Using the ankle for measurement of non-invasive blood pressure (NIBP) was previously evaluated in normal subjects, and was reported to be feasible; however, its normal range differed from the arm NIBP. Under spinal anesthesia, the lower limb of the mother is neither mobile, nor sensate. Thus, it was previously hypothesized that measurement of blood pressure at the ankle of the mother could improve patient comfort. Darke and Hill had evaluated the accuracy of non-invasive blood pressure at the arm and the ankle during cesarean delivery. Darke and Hill had reported that the degree of bias between the two sites is not acceptable; however, their study did not evaluate the accuracy of ankle NIBP as a trend monitor to trace the changes in maternal blood pressure. The aim of this work is to evaluate the accuracy and precision of ankle NIBP as a trend monitor in mothers undergoing cesarean delivery under spinal anesthesia.

NCT ID: NCT04173208 Active, not recruiting - Clinical trials for Fecal Microbiota Transplantation

Main Trial of the Cesarean Section and Intestinal Flora of the Newborn Study

MT-SECFLOR
Start date: November 10, 2019
Phase: N/A
Study type: Interventional

In this study the investigators assess whether, in CS-delivered infants, the intestinal microbiome could be successfully and safely normalised by postnatal oral transfer of maternal fecal microbiome.

NCT ID: NCT04163679 Terminated - Infection Clinical Trials

Vaginal Preparation and Azithromycin to Reduce Post Cesarean Infections

Start date: September 18, 2019
Phase: N/A
Study type: Interventional

asdgf

NCT ID: NCT04159948 Recruiting - Fasting Clinical Trials

Preoperative Carbohydrate Drink Prior to Elective Caesarean Section

Start date: January 20, 2020
Phase: N/A
Study type: Interventional

Prior to caesarean section, patients should fast from solid food for 6 hours and from clear fluids for 2 hours. Carbohydrate drinks can also be consumed up to 2 hours before surgery. These drinks have been shown to improve patient well-being after surgery and may potentially improve the neonatal blood glucose level after delivery and reduce the risk of a low blood glucose level. This study aims to assess the influence of pre-operative carbohydrate drinks on blood glucose levels of the baby at delivery.